Find a company
TCC-CASEMIX® offers a fundamental new service to manage safety in use of medical devices in surgery. For the first time, there is total transparency of this use (as recommended by Cumberlege), set in the context of patient risk factors and post-surgical outcomes. The service is deployed as a cloud-based infrastructure of inter-connected and open registries providing access to device performance data from different stakeholder perspectives.
It is within this infrastructure that TCC-CASEMIX is developing PredictOR Carbon Analytics – another dimension of medical device performance in the surgical pathway. Working with a large group of medical device manufacturers we are on a mission to identify how and where carbon is embodied in the surgical pathway. The outcome will transform patient informed consent.
| Project | PredictOR Carbon Analytics |
|---|---|
| Description |
TCC-CASEMIX® offers a fundamental new service to manage safety in use of medical devices in surgery. For the first time, there is total transparency of this use (as recommended by Cumberlege), set in the context of patient risk factors and post-surgical outcomes. The service is deployed as a cloud-based infrastructure of inter-connected and open registries providing access to device performance data from different stakeholder perspectives. It is within this infrastructure that TCC-CASEMIX is developing PredictOR Carbon Analytics – another dimension of medical device performance in the surgical pathway. Working with a large group of medical device manufacturers we are on a mission to identify how and where carbon is embodied in the surgical pathway. The outcome will transform patient informed consent. |
| Funding | £ 81,137 |
| Competition | Competition 18 - Delivering a Net Zero NHS |
| Competition Date | July 2021 |
| Health Innovation Network Partner | Health Innovation East Midlands |
| Website | https://www.conclude.org.uk |